These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12584226)

  • 1. A large population study of spontaneous HBeAg seroconversion and acute exacerbation of chronic hepatitis B infection: implications for antiviral therapy.
    Yuen MF; Yuan HJ; Hui CK; Wong DK; Wong WM; Chan AO; Wong BC; Lai CL
    Gut; 2003 Mar; 52(3):416-9. PubMed ID: 12584226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?
    Song BC; Cho YK; Jwa H; Choi EK; Kim HU; Song HJ; Na SY; Boo SJ; Jeong SU
    Clin Mol Hepatol; 2014 Dec; 20(4):355-60. PubMed ID: 25548741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline Level of Hepatitis B Core Antibody Predicts Spontaneous Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg-Positive Children With a Normal Alanine Aminotransferase Level.
    Chen HS; Wu JF; Su TH; Chen HL; Hsu HY; Xia NS; Chen PJ; Chang MH
    Hepatology; 2019 Dec; 70(6):1903-1912. PubMed ID: 31121067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of chronic hepatitis B: case selection and duration of therapy.
    Leung N
    J Gastroenterol Hepatol; 2002 Apr; 17(4):409-14. PubMed ID: 11982721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamivudine therapy for children with chronic hepatitis B.
    Liberek A; Szaflarska-Popławska A; Korzon M; Łuczak G; Góra-Gebka M; Łoś-Rycharska E; Bako W; Czerwionka-Szaflarska M
    World J Gastroenterol; 2006 Apr; 12(15):2412-6. PubMed ID: 16688835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B. Asian Hepatitis Lamivudine Trial Group.
    Chien RN; Liaw YF; Atkins M
    Hepatology; 1999 Sep; 30(3):770-4. PubMed ID: 10462384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors for early HBeAg seroconversion in acute exacerbation of patients with HBeAg-positive chronic hepatitis B.
    Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    Gastroenterology; 2009 Feb; 136(2):505-12. PubMed ID: 19101558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications.
    Yuen MF; Yuan HJ; Wong DK; Yuen JC; Wong WM; Chan AO; Wong BC; Lai KC; Lai CL
    Gut; 2005 Nov; 54(11):1610-4. PubMed ID: 15871997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy.
    Leung NW; Lai CL; Chang TT; Guan R; Lee CM; Ng KY; Lim SG; Wu PC; Dent JC; Edmundson S; Condreay LD; Chien RN;
    Hepatology; 2001 Jun; 33(6):1527-32. PubMed ID: 11391543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
    Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC
    Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral therapy in hepatitis B virus-infected children with immune-tolerant characteristics: A pilot open-label randomized study.
    Zhu S; Zhang H; Dong Y; Wang L; Xu Z; Liu W; Gan Y; Tang H; Chen D; Wang F; Zhao P
    J Hepatol; 2018 Jun; 68(6):1123-1128. PubMed ID: 29452204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viremia profiles in children with chronic hepatitis B virus infection and spontaneous e antigen seroconversion.
    Ni YH; Chang MH; Chen PJ; Tsai KS; Hsu HY; Chen HL; Tsuei DJ; Chen DS
    Gastroenterology; 2007 Jun; 132(7):2340-5. PubMed ID: 17570209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural History of Chronic Hepatitis B Virus Infection in Ahvaz City, Iran.
    Makvandi M; Soleimani Jelodar R; Samarbafzadeh A; Neisi N; Sharifi Z; Gholampour A; Masjedizadeh A; Shayesteh A
    Asian Pac J Cancer Prev; 2018 Aug; 19(8):2125-2129. PubMed ID: 30139211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B core antibody and liver stiffness measurements predict HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients with minimally elevated alanine aminotransferase (ALT) levels.
    Fu X; Lou H; Chen F; Gao X; Lin Z
    Clin Exp Med; 2020 May; 20(2):241-248. PubMed ID: 32052245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase.
    van Nunen AB; Hansen BE; Suh DJ; Löhr HF; Chemello L; Fontaine H; Heathcote J; Song BC; Janssen HL; de Man RA; Schalm SW
    Gut; 2003 Mar; 52(3):420-4. PubMed ID: 12584227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of adefovir therapy in chronic hepatitis B according to baseline predictors and on-treatment HBV DNA: a 5-year prospective study.
    Lu H; Geng da Y; Shen F; Zhang JY; Lu B; Ma LX
    Virol J; 2011 Sep; 8():444. PubMed ID: 21936898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.
    Hsu YS; Chien RN; Yeh CT; Sheen IS; Chiou HY; Chu CM; Liaw YF
    Hepatology; 2002 Jun; 35(6):1522-7. PubMed ID: 12029639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive effect of serial serum alanine aminotransferase levels on spontaneous HBeAg seroconversion in chronic genotype B and C HBV-infected children.
    Wu JF; Su YR; Chen CH; Chen HL; Ni YH; Hsu HY; Wang JL; Chang MH
    J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):97-100. PubMed ID: 21716132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four years of lamivudine treatment in Chinese patients with chronic hepatitis B.
    Chang TT; Lai CL; Chien RN; Guan R; Lim SG; Lee CM; Ng KY; Nicholls GJ; Dent JC; Leung NW
    J Gastroenterol Hepatol; 2004 Nov; 19(11):1276-82. PubMed ID: 15482535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term lamivudine therapy in patients with chronic hepatitis B.
    Chien RN; Liaw YF
    Intervirology; 2003; 46(6):362-6. PubMed ID: 14688453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.